Mar 14, 2022
A prospective, double blind, superiority, randomized
placebo-controlled trial conducted to confirm the rapid onset
anti-suicidal benefits of ketamine in the short term and at six
Season-3 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.
Having trouble logging in?